139 related articles for article (PubMed ID: 18921992)
1. Rational design and synthesis of 4-((1R,2R)-2-hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a novel, nonsteroidal androgen receptor antagonist devoid of phototoxicity for dermatological indications.
Li JJ; Iula DM; Nguyen MN; Hu LY; Dettling D; Johnson TR; Du DY; Shanmugasundaram V; Van Camp JA; Wang Z; Harter WG; Yue WS; Boys ML; Wade KJ; Drummond EM; Samas BM; Lefker BA; Hoge GS; Lovdahl MJ; Asbill J; Carroll M; Meade MA; Ciotti SM; Krieger-Burke T
J Med Chem; 2008 Nov; 51(21):7010-4. PubMed ID: 18921992
[TBL] [Abstract][Full Text] [Related]
2. Preparation of 4-aryl-2-trifluoromethylbenzonitrile derivatives as androgen receptor antagonists for topical suppression of sebum production.
Van Camp JA; Hu LY; Kostlan C; Lefker B; Li J; Mitchell L; Wang Z; Yue WS; Carroll M; Dettling D; Du D; Pocalyko D; Wade K
Bioorg Med Chem Lett; 2007 Oct; 17(20):5529-32. PubMed ID: 17764935
[TBL] [Abstract][Full Text] [Related]
3. (1R,2S)-4-(2-cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile, a potent androgen receptor antagonist for stimulating hair growth and reducing sebum production.
Hu LY; Du D; Hoffman J; Smith Y; Fedij V; Kostlan C; Johnson TR; Huang Y; Kesten S; Harter W; Yue WS; Li JJ; Barvian N; Mitchell L; Lei HJ; Lefker B; Carroll M; Dettling D; Krieger-Burke T; Samas B; Yalamanchili R; Lapham K; Pocalyko D; Sliskovic D; Ciotti S; Stoller B; Hena MA; Ding Q; Maiti SN; Stier M; Welgus H
Bioorg Med Chem Lett; 2007 Nov; 17(21):5983-8. PubMed ID: 17827000
[TBL] [Abstract][Full Text] [Related]
4. 4-(Alkylthio)- and 4-(arylthio)-benzonitrile derivatives as androgen receptor antagonists for the topical suppression of sebum production.
Mitchell L; Wang Z; Hu LY; Kostlan C; Carroll M; Dettling D; Du D; Pocalyko D; Wade K
Bioorg Med Chem Lett; 2009 Mar; 19(5):1310-3. PubMed ID: 19201190
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of amino-pyridines as androgen receptor antagonists for stimulating hair growth and reducing sebum production.
Hu LY; Lei HJ; Du D; Johnson TR; Fedij V; Kostlan C; Yue WS; Lovdahl M; Li JJ; Carroll M; Dettling D; Asbill J; Fan C; Wade K; Pocalyko D; Lapham K; Yalamanchili R; Samas B; Vrieze D; Ciotti S; Krieger-Burke T; Sliskovic D; Welgus H
Bioorg Med Chem Lett; 2007 Oct; 17(20):5693-7. PubMed ID: 17766112
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, structure-activity relationships, and characterization of novel nonsteroidal and selective androgen receptor modulators.
Schlienger N; Lund BW; Pawlas J; Badalassi F; Bertozzi F; Lewinsky R; Fejzic A; Thygesen MB; Tabatabaei A; Bradley SR; Gardell LR; Piu F; Olsson R
J Med Chem; 2009 Nov; 52(22):7186-91. PubMed ID: 19856921
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of 4-[3,5-dioxo-11-oxa-4,9-diazatricyclo[5.3.1.0(2,6)]undec-4-yl]-2-trifluoromethyl-benzonitriles as androgen receptor antagonists.
Xiao HY; Balog A; Attar RM; Fairfax D; Fleming LB; Holst CL; Martin GS; Rossiter LM; Chen J; Cvjic ME; Dell-John J; Geng J; Gottardis MM; Han WC; Nation A; Obermeier M; Rizzo CA; Schweizer L; Spires T; Shan W; Gavai A; Salvati ME; Vite G
Bioorg Med Chem Lett; 2010 Aug; 20(15):4491-5. PubMed ID: 20584610
[TBL] [Abstract][Full Text] [Related]
8. Discovery and structure-activity relationships of new steroidal compounds bearing a carboxy-terminal side chain as androgen receptor pure antagonists.
Tachibana K; Imaoka I; Yoshino H; Kato N; Nakamura M; Ohta M; Kawata H; Taniguchi K; Ishikura N; Nagamuta M; Onuma E; Sato H
Bioorg Med Chem Lett; 2007 Oct; 17(20):5573-6. PubMed ID: 17804229
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and in vivo SAR of a novel series of pyrazolines as potent selective androgen receptor modulators.
Zhang X; Li X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
J Med Chem; 2007 Aug; 50(16):3857-69. PubMed ID: 17636947
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of carborane-containing androgen receptor (AR) antagonist bearing a pyridine ring.
Ohta K; Goto T; Fijii S; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem; 2008 Sep; 16(17):8022-8. PubMed ID: 18707892
[TBL] [Abstract][Full Text] [Related]
11. 6-Aryl-4-methylsulfanyl-2H-pyran-2-one-3-carbonitriles as PPAR-gamma activators.
Sharon A; Pratap R; Vatsyayan R; Maulik PR; Roy U; Goel A; Ram VJ
Bioorg Med Chem Lett; 2005 Jul; 15(14):3356-60. PubMed ID: 15953723
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of new bioactive venlafaxine analogs: novel thiazolidin-4-ones as antimicrobials.
Kavitha CV; Basappa ; Swamy SN; Mantelingu K; Doreswamy S; Sridhar MA; Shashidhara Prasad J; Rangappa KS
Bioorg Med Chem; 2006 Apr; 14(7):2290-9. PubMed ID: 16338140
[TBL] [Abstract][Full Text] [Related]
13. (+)-(2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an orally potent and peripherally selective nonsteroidal androgen receptor antagonist.
Kinoyama I; Taniguchi N; Toyoshima A; Nozawa E; Kamikubo T; Imamura M; Matsuhisa A; Samizu K; Kawanimani E; Niimi T; Hamada N; Koutoku H; Furutani T; Kudoh M; Okada M; Ohta M; Tsukamoto S
J Med Chem; 2006 Jan; 49(2):716-26. PubMed ID: 16420057
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity investigation of iodinated arylhydantoins and arylthiohydantoins for development as androgen receptor radioligands.
Van Dort ME; Jung YW
Bioorg Med Chem Lett; 2004 Nov; 14(21):5285-8. PubMed ID: 15454212
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of agonicity and antagonicity in the androgen receptor studied by molecular dynamics simulations.
Bisson WH; Abagyan R; Cavasotto CN
J Mol Graph Model; 2008 Nov; 27(4):452-8. PubMed ID: 18805032
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of androgen receptor antagonists with bulky side chains for overcoming antiandrogen resistance.
Zhou J; Geng G; Shi Q; Sauriol F; Wu JH
J Med Chem; 2009 Sep; 52(17):5546-50. PubMed ID: 19725582
[TBL] [Abstract][Full Text] [Related]
17. Rational design of a topical androgen receptor antagonist for the suppression of sebum production with properties suitable for follicular delivery.
Mitchell LH; Johnson TR; Lu GW; Du D; Datta K; Grzemski F; Shanmugasundaram V; Spence J; Wade K; Wang Z; Sun K; Lin K; Hu LY; Sexton K; Raheja N; Kostlan C; Pocalyko D
J Med Chem; 2010 Jun; 53(11):4422-7. PubMed ID: 20462217
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of nonsteroidal cycloalkane[d]isoxazole-containing androgen receptor modulators.
Poutiainen PK; Oravilahti T; Peräkylä M; Palvimo JJ; Ihalainen JA; Laatikainen R; Pulkkinen JT
J Med Chem; 2012 Jul; 55(14):6316-27. PubMed ID: 22746350
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure, docking study and structure-activity relationship of carborane-containing androgen receptor antagonist 3-(12-hydroxymethyl-1,12-dicarba-closo-dodecaboran-1-yl)benzonitrile.
Ohta K; Goto T; Fujii S; Kawahata M; Oda A; Ohta S; Yamaguchi K; Hirono S; Endo Y
Bioorg Med Chem; 2011 Jun; 19(11):3540-8. PubMed ID: 21536446
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and SAR of potent and selective androgen receptor antagonists: 5,6-Dichloro-benzimidazole derivatives.
Ng RA; Guan J; Alford VC; Lanter JC; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
Bioorg Med Chem Lett; 2007 Feb; 17(3):784-8. PubMed ID: 17095226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
